The MedicX Fund Limited Issue of Ordinary Shares (5114S)
June 25 2018 - 11:27AM
UK Regulatory
TIDMMXF
RNS Number : 5114S
The MedicX Fund Limited
25 June 2018
For immediate release
25 June 2018
MedicX Fund Limited
("MedicX", "the Fund" or "the Company")
Issue of Ordinary Shares
MedicX Fund Limited (the "Company") announces that earlier
today, Monday 25 June 2018, it issued for cash 1,000,000 ordinary
shares of no par value in the Company. The ordinary shares were
issued under the Company's block listing facility, at a price of
81.25 pence per share.
The net proceeds raised will be used by the Company for general
commercial purposes.
Total voting rights
In accordance with the Financial Conduct Authority's Disclosure
and Transparency Rules, the total number of ordinary shares of the
Company in issue following this transaction will be 442,430,576
shares (excluding treasury shares) each with one voting right. The
above figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in the
Company, under the Disclosure and Transparency Rules.
As at today's date, the Company also holds 3,271,823 ordinary
shares in treasury. Following the sale out of treasury of 368,440
ordinary shares in lieu of cash for the June 2018 dividend, payable
on 29 June 2018 (as announced on 13 June 2018), the Company is
expected to have 2,903,383 ordinary shares held in treasury.
The Company has 5,071,668 ordinary shares of no par value
remaining under its block listing facility to be used to satisfy
demand that cannot be met through the secondary market.
End
For further information please contact:
Octopus Healthcare Adviser Limited +44 (0) 345 0404 5555
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Executive Chairman
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Henry Wilson
Canaccord Genuity Limited +44 (0) 20 7523 8000
Robbie Robertson/Andrew Zychowski/Helen Goldsmith
Liberum +44 (0) 20 3100 2000
Richard Crawley/Jamie Richards
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the
"Company", or together with its subsidiaries, the "Group") is a
specialist primary care infrastructure investor in modern,
purpose-built primary healthcare properties in the United Kingdom
and Ireland, listed on the London Stock Exchange, with a portfolio
comprising 166 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1.4 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP7.7 billion of funds for more than 50,000 retail and
institutional investors as well as supplying energy to more than
180,000 customers.
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or form
part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
IOESEDFIIFASEEM
(END) Dow Jones Newswires
June 25, 2018 11:27 ET (15:27 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024